Tractian vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
Industrial predictive maintenance platform using IoT sensors on motors and pumps; ML vibration analysis detecting bearing failures before breakdowns competing with Augury for manufacturers.
About
Tractian is an AI-powered predictive maintenance and industrial asset monitoring platform that uses IoT vibration and temperature sensors attached to industrial equipment (pumps, motors, gearboxes, fans, compressors) to continuously monitor machine health — detecting early signs of equipment failure before breakdowns occur and providing actionable maintenance recommendations. Founded in 2019 by Igor Marinelli and Gabriel Lameirinhas in São Paulo, Brazil, Tractian has raised approximately $45 million and serves industrial manufacturers across automotive, food and beverage, chemical, and consumer goods sectors in Brazil and the US.\n\nTractian's system combines wireless IoT sensors that attach magnetically to rotating equipment with a cloud analytics platform that uses machine learning to analyze vibration signatures. As a bearing deteriorates, gearbox oil breaks down, or a pump cavitates, characteristic vibration frequency patterns change — Tractian's AI detects these anomalies and alerts maintenance teams to address the issue before failure. The platform calculates equipment health scores and estimates time-to-failure, enabling planned maintenance during scheduled downtime rather than emergency repairs.\n\nIn 2025, Tractian competes in the industrial predictive maintenance market against Augury (the well-funded US leader in AI machine health), SKF (the Swedish bearing company with its own condition monitoring), Emerson's Plantweb, and general IIoT platforms like PTC ThingWorx. The predictive maintenance market has grown as industrial manufacturers recognize that unplanned downtime costs significantly more than planned maintenance. Tractian's Latin American roots give it strong market position in Brazil while it expands aggressively in the US market. The 2025 strategy focuses on US manufacturing expansion, adding new equipment types to its monitoring capabilities, and integrating with CMMS (computerized maintenance management system) platforms for maintenance workflow automation.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.